4
Changes in Ownership
Ovid Therapeutics Inc. Filed Acc 0001209191-22-024191
Options or other derivatives
- Chief Operating Officer acquired 97,498 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Tardio Jason Chief Operating Officer | 2022-04-08 | Grant or award · Stock Option (Right to Buy) | +87,498 | 87,498 | D | ||
| Tardio Jason Chief Operating Officer | 2022-04-08 | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | D | ||
Loading xslF345X03/doc4.xml…